Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in T2D with Metformin and Basal Insulin (VIBE)
NCT01757587Phase 4Completed
- Sponsor
- CERITD
- Start
- Dec 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by CERITD. Started Dec 2011; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01757587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757587.